|
End-of-day quote
Shenzhen S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 8.180 CNY | -1.21% |
|
-10.89% | +3.02% |
| Market Cap | 4.76B 713M 635M 588M 536M 1.01B 67.67B 1.03B 7.07B 2.77B 35.35B 2.67B 2.62B 113B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.59B 687M 613M 567M 517M 973M 65.27B 990M 6.82B 2.68B 34.09B 2.58B 2.52B 109B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | -1.21% | ||
| 1 week | -10.89% | ||
| Current month | -14.44% | ||
| 1 month | +3.68% | ||
| 3 months | -4.88% | ||
| 6 months | -21.80% | ||
| Current year | +3.02% |
| 1 week | 8.09 |  | 9.35 |
| 1 month | 7.88 | | 10.43 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -10.89% | -6.73% | +12.36% | 720M | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,116B | |
| +0.90% | -0.36% | +33.68% | +62.93% | 610B | |
| +0.71% | +4.77% | +26.17% | +92.90% | 501B | |
| +0.52% | +2.51% | +73.52% | +40.32% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +6.15% | +45.46% | +52.23% | 235B | |
| -0.75% | +6.18% | +32.03% | +101.15% | 195B | |
| Average | -0.35% | +4.04% | +30.80% | +57.28% | 393.05B | |
| Weighted average by Cap. | -0.17% | +4.93% | +38.82% | +72.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 131M 122M 111M 209M 13.99B 212M 1.46B 573M 7.31B 553M 541M 23.27B | 1.21B 181M 161M 149M 136M 256M 17.14B 260M 1.79B 703M 8.95B 677M 663M 28.52B |
| Net income | 13.65M 2.04M 1.82M 1.69M 1.54M 2.9M 194M 2.94M 20.3M 7.96M 101M 7.67M 7.51M 323M | 92.73M 13.89M 12.38M 11.46M 10.44M 19.67M 1.32B 20M 138M 54.07M 689M 52.12M 51.01M 2.19B |
| Net Debt | 189M 28.32M 25.24M 23.36M 21.28M 40.11M 2.69B 40.78M 281M 110M 1.4B 106M 104M 4.47B | -169M -25.28M -22.53M -20.85M -19M -35.81M -2.4B -36.41M -251M -98.42M -1.25B -94.88M -92.86M -3.99B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | CN¥8.180 | -1.21% | 43,976,450 |
| 15/10/26 | CN¥8.280 | -0.72% | 35,122,233 |
| 14/10/26 | CN¥8.340 | -3.81% | 22,942,600 |
| 13/10/26 | CN¥8.670 | -1.37% | 25,195,614 |
| 12/10/26 | CN¥8.790 | -4.04% | 26,055,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
